Filing Details
- Accession Number:
- 0001144204-19-018782
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-04-09 11:31:17
- Reporting Period:
- 2016-12-16
- Accepted Time:
- 2019-04-09 11:31:17
- Original Submission Date:
- 2019-04-05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1586554 | Target Group Inc. | CBDY | Medicinal Chemicals & Botanical Products (2833) | 463610035 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635865 | Sasha Starr | 1131A Leslie Street Suite 101 Toronto A6 M3C 3L8 | President/Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-03 | 8,234,850 | $0.02 | 17,454,056 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-03-18 | 2,500 | $0.11 | 9,219,206 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-03-18 | 17,000 | $0.08 | 9,221,706 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-03-07 | 1,764,706 | $0.02 | 9,238,706 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Preferred Stock | Disposition | 2019-02-22 | 500,000 | $0.00 | 0 | $0.00 |
| Common Stock | Preferred stock | Acquisiton | 2016-12-16 | 500,000 | $0.00 | 500,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-04 | No | 4 | D | Direct | |
| 500,000 | 2017-02-04 | No | 4 | A | Direct |
Footnotes
- The shares were issued pursuant to Reporting Person's employment agreement in lieu of cash compensation.
- One (1) share of common stock is issuable for each one (1) share of preferred upon conversion.
- There is no expiration date for the exercise of the conversion rights of the preferred stock.
- The preferred shares were issued in consideration of $13,250 of deferred and unpaid compensation owed by the Issuer to the Reporting Person.
- The preferred shares were sold by the Reporting Person in a private transaction to a single purchaser in consideration of a cash payment of CND $250,000.00 (US$190,000.00).
Billionaire Hedge Funds
